Rockwell Medical (RMTI) Amortizatization of Intangibles (2019 - 2026)
Rockwell Medical (RMTI) reported Amortizatization of Intangibles of $102000.0 for Q1 2026, down 26.62% on a YoY basis from $139000.0 in Q1 2025, and up 0.99% quarter-over-quarter from $101000.0 in Q4 2025.
Rockwell Medical (RMTI) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Rockwell Medical has reported Amortizatization of Intangibles for 8 years, with the latest figure at $102000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 26.62% year-over-year to $102000.0; the trailing twelve-month figure through Mar 2026 stood at $451000.0 (down 19.03% YoY), and the FY2025 full-year result was $488000.0, down 12.7% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $102000.0, up from $101000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $1.6 million in Q4 2022, with the low at $101000.0 in Q4 2025.
- Historically, Amortizatization of Intangibles has averaged $219176.5 across 5 years, with a median of $141000.0 in 2022.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles soared 197.01% — and 2023, when it plunged 91.13%.
- Rockwell Medical's Amortizatization of Intangibles stood at $1.6 million in 2022, then sank by 91.13% to $141000.0 in 2023, then fell by 2.13% to $138000.0 in 2024, then dropped by 26.81% to $101000.0 in 2025, then advanced by 0.99% to $102000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $102000.0 (Q1 2026), $101000.0 (Q4 2025), and $109000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Rockwell Medical | 26.31 Mn | 2.42 Mn | 2.90 Mn | 102,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102,000.00 |
| Mar 31, 2026 | 102,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Sep 30, 2025 | 109,000.00 |
| Sep 30, 2025 | 109,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 139,000.00 |
| Mar 31, 2025 | 139,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Sep 30, 2024 | 139,000.00 |
| Sep 30, 2024 | 139,000.00 |
| Jun 30, 2024 | 141,000.00 |
| Jun 30, 2024 | 141,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Dec 31, 2023 | 141,000.00 |
| Dec 31, 2023 | 141,000.00 |